These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 11590875)
1. N-3 fatty acids and cardiac function after myocardial infarction in Denmark. Skou HA; Toft E; Christensen JH; Hansen JB; Dyerberg J; Schmidt EB Int J Circumpolar Health; 2001 Aug; 60(3):360-5. PubMed ID: 11590875 [TBL] [Abstract][Full Text] [Related]
2. Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids. Macchia A; Levantesi G; Franzosi MG; Geraci E; Maggioni AP; Marfisi R; Nicolosi GL; Schweiger C; Tavazzi L; Tognoni G; Valagussa F; Marchioli R; Eur J Heart Fail; 2005 Aug; 7(5):904-9. PubMed ID: 16087142 [TBL] [Abstract][Full Text] [Related]
3. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. Murcia AM; Hennekens CH; Lamas GA; Jiménez-Navarro M; Rouleau JL; Flaker GC; Goldman S; Skali H; Braunwald E; Pfeffer MA Arch Intern Med; 2004 Nov; 164(20):2273-9. PubMed ID: 15534166 [TBL] [Abstract][Full Text] [Related]
4. N-3 polyunsaturated fatty acids early supplementation improves ultrasound indices of endothelial function, but not through NO inhibitors in patients with acute myocardial infarction: N-3 PUFA supplementation in acute myocardial infarction. Haberka M; Mizia-Stec K; Mizia M; Janowska J; Gieszczyk K; Chmiel A; Zahorska-Markiewicz B; Gąsior Z Clin Nutr; 2011 Feb; 30(1):79-85. PubMed ID: 20705373 [TBL] [Abstract][Full Text] [Related]
5. C-reactive protein and n-3 fatty acids in patients with a previous myocardial infarction: a placebo-controlled randomized study. Madsen T; Christensen JH; Schmidt EB Eur J Nutr; 2007 Oct; 46(7):428-30. PubMed ID: 17676423 [TBL] [Abstract][Full Text] [Related]
6. Effects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study. Laake K; Myhre P; Nordby LM; Seljeflot I; Abdelnoor M; Smith P; Tveit A; Arnesen H; Solheim S BMC Geriatr; 2014 Jun; 14():74. PubMed ID: 24928284 [TBL] [Abstract][Full Text] [Related]
7. Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure. Pitt B; White H; Nicolau J; Martinez F; Gheorghiade M; Aschermann M; van Veldhuisen DJ; Zannad F; Krum H; Mukherjee R; Vincent J; J Am Coll Cardiol; 2005 Aug; 46(3):425-31. PubMed ID: 16053953 [TBL] [Abstract][Full Text] [Related]